LACQUANITI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 6.656
EU - Europa 6.078
AS - Asia 3.090
SA - Sud America 931
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 115
OC - Oceania 7
Totale 17.050
Nazione #
US - Stati Uniti d'America 6.442
RU - Federazione Russa 3.294
SG - Singapore 1.142
CN - Cina 1.025
BR - Brasile 784
IE - Irlanda 688
SE - Svezia 645
IT - Italia 338
HK - Hong Kong 291
DE - Germania 276
FR - Francia 212
FI - Finlandia 157
GB - Regno Unito 155
VN - Vietnam 151
IN - India 121
UA - Ucraina 84
CA - Canada 81
BD - Bangladesh 77
PL - Polonia 73
AR - Argentina 52
TR - Turchia 40
MX - Messico 34
BE - Belgio 30
EC - Ecuador 29
ES - Italia 29
ZA - Sudafrica 29
IQ - Iraq 27
IL - Israele 24
CO - Colombia 22
ID - Indonesia 22
JP - Giappone 20
PK - Pakistan 20
CZ - Repubblica Ceca 19
MA - Marocco 19
NL - Olanda 19
AE - Emirati Arabi Uniti 16
UZ - Uzbekistan 16
CR - Costa Rica 15
VE - Venezuela 14
GP - Guadalupe 13
KE - Kenya 13
SC - Seychelles 13
AT - Austria 12
JM - Giamaica 12
NI - Nicaragua 11
GT - Guatemala 10
PH - Filippine 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
HN - Honduras 8
PE - Perù 8
JO - Giordania 7
MY - Malesia 7
SA - Arabia Saudita 7
TN - Tunisia 7
UY - Uruguay 7
AM - Armenia 6
CI - Costa d'Avorio 6
CW - ???statistics.table.value.countryCode.CW??? 6
DO - Repubblica Dominicana 6
EG - Egitto 6
NP - Nepal 6
PS - Palestinian Territory 6
AU - Australia 5
CL - Cile 5
DZ - Algeria 5
KG - Kirghizistan 5
PR - Porto Rico 5
BG - Bulgaria 4
BH - Bahrain 4
CH - Svizzera 4
LT - Lituania 4
SN - Senegal 4
SV - El Salvador 4
TH - Thailandia 4
TW - Taiwan 4
BO - Bolivia 3
BY - Bielorussia 3
EE - Estonia 3
GA - Gabon 3
GY - Guiana 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AO - Angola 2
BN - Brunei Darussalam 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
Totale 16.854
Città #
Ashburn 1.136
Moscow 868
Dublin 687
Singapore 632
Dallas 591
Chandler 587
San Jose 476
Beijing 342
Nyköping 326
Hong Kong 289
New York 234
Jacksonville 229
The Dalles 158
Council Bluffs 150
Los Angeles 130
Dearborn 128
Ann Arbor 119
Munich 104
Princeton 103
Lauterbourg 101
Medford 101
Messina 98
Cambridge 97
Des Moines 73
São Paulo 62
Warsaw 61
Boardman 58
Houston 52
Santa Clara 51
Buffalo 49
Ho Chi Minh City 47
Bremen 46
Jinan 45
San Mateo 45
Shenyang 38
Tianjin 38
Turku 36
Orem 35
Pune 35
Lancaster 34
North Bergen 34
Shanghai 34
Hanoi 32
Hyderabad 32
Redondo Beach 31
Brooklyn 30
Frankfurt am Main 30
Guangzhou 30
Phoenix 29
Wilmington 28
Brussels 27
Seattle 27
Rio de Janeiro 25
Woodbridge 25
Brasília 24
Hebei 24
Nanjing 23
Lentini 22
Curitiba 21
Helsinki 21
Milan 21
Atlanta 20
Belo Horizonte 20
Düsseldorf 20
Denver 18
Tokyo 18
Chennai 17
Columbus 17
Montreal 17
Poplar 17
Rome 17
San Francisco 17
Stockholm 16
London 15
Naples 15
Ningbo 15
Toronto 15
Boston 14
Hangzhou 14
Nanchang 14
Shenzhen 14
Tashkent 14
Zhengzhou 14
Ankara 13
Charlotte 13
Chicago 13
Newark 13
Philadelphia 13
Baghdad 12
Johannesburg 12
Porto Alegre 12
San José 12
Haikou 11
Istanbul 11
Jakarta 11
Jiaxing 11
Managua 11
Amsterdam 10
Nairobi 10
Nuremberg 10
Totale 9.617
Nome #
3 Tesla-Diffusion Tensor Imaging in Autosomal Dominant Polycystic Kidney Disease: The Nephrologist's Point of View 313
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 284
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 251
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 248
[From hyponatremia to tolvaptan] 241
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 237
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 236
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 228
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 224
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 222
Sclerostin levels in uremic patients: a link between bone and vascular disease 217
Central precocious puberty: from physiopathological mechanisms to treatment. 215
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 206
Dialysis and the Elderly: An Underestimated Problem. 205
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? 205
Fibrosis, regeneration and cancer: what is the link? 201
Down with the erythropoietin. Long live the erythropoietin! 200
The Myth of Water and Salt: From Aquaretics to Tenapanor 200
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children 198
High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis 195
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 193
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: Serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment 190
A new therapy for kidney injury: regeneration. 188
Emerging markers of cachexia predict survival in cancer patients. 187
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 187
Hydrocarbons and kidney damage: Potential use of neutrophil gelatinase-associated lipocalin and sister chromatide exchange 186
A Biotechnological T-Shirt Monitors the Patient's Heart during Hemodialysis. 185
The erythropoietin and regenerative medicine: a lesson from fish 184
Kidney disease and psoriasis: novel evidences beyond old concepts 182
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 181
La Genotossicità nel Paziente Uremico: un modello di studio sorprendente. 180
Before and after preeclampsia: What biomarkers are there? 178
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 178
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 177
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 177
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 176
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 174
Erythropoietin and the truths of science. 173
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 173
From chronic kidney disease to transplantation: the roles of obestatin. 168
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 167
High-mobility group box 1 in allergic and non allergic upper airway inflammation 166
Persistent left superior vena cava and partially left inferior vena cava: A case report of a dangerous central venous catheterization 164
Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin 161
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 161
[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)] 161
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 160
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker 159
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 158
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 158
From water to aquaretics: a legendary route. 158
Regenerative medicine: does Erythropoietin have a role? 158
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair. 157
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 156
Kidney-lung connections in acute and chronic diseases: current perspectives 156
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 155
Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis. 155
Malnutrition in the elderly patient on dialysis. 154
Renal complications in oncohematologic patients. 153
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 153
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 152
Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients 150
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 150
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 148
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 146
New options for the management of polycystic kidney disease 145
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 144
Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease 144
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 143
LMNA gene mutation as a model of cardiometabolic dysfunction: From genetic analysis to treatment response. 142
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 142
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 141
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 141
Renal biopsy: Still a landmark for the nephrologist 140
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 137
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 136
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 135
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 133
Transient diabetes insipidus in pregnancy, diagnostic role of apelin and copeptin: A case report 131
Does Erythropoietin Always Win? 129
Vitamin D intoxication in two brothers: be careful with dietary supplements. 128
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 127
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 127
Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction 126
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 124
NGAL is a precocious marker of therapeutic response. 123
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 123
Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum. 121
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 116
Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney Disease 111
Obestatin: an interesting but controversial gut hormone. 109
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 109
Surgical Aortic Valve Replacement and Renal Dysfunction: From Acute Kidney Injury to Chronic Disease 108
The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis 102
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 102
Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques. 98
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 98
The future of phosphate binders: a perspective on novel therapeutics 97
Increase in creatinine for the prediction of contrast-induced nephropathy 97
New available biomarkers to face a worldwide emergency: The childhood obesity 94
Totale 16.382
Categoria #
all - tutte 56.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022638 0 0 0 0 40 7 53 40 9 173 86 230
2022/20232.048 146 229 95 149 176 197 14 127 849 11 38 17
2023/2024626 33 70 22 53 49 259 7 22 8 37 7 59
2024/20252.414 42 26 49 142 85 103 87 461 568 196 265 390
2025/20268.067 444 503 622 539 656 1.525 969 1.062 1.027 331 174 215
2026/20271.312 135 362 331 404 80 0 0 0 0 0 0 0
Totale 17.050